A new study by MIT researchers investigates how roundworms are able to sense the color blue to avoid dangerous bacteria that secrete toxins, reports Veronique Greenwood for The New York Times. Greenwood found that “some roundworms respond clearly to that distinctive pigment, perceiving it — and fleeing from it — without the benefit of any known visual system.”
UPI reporter Brooks Hays writes that MIT researchers have developed a new machine learning algorithm that can anticipate and recognize a protein’s varied structures. “The new AI-system,” writes Hays, “does more than image a diversity of conformations, it can also predict the varied motions of different protein structures.”
In an opinion piece for The Los Angeles Times, Institute Professor Phillip Sharp, Ellen Sigal of the Friends of Cancer Research and Sherry Lansing of the Sherry Lansing Foundation underscore the importance of selecting an effective leader for the FDA. “In order to restore trust in the FDA, and restore morale within, a permanent leader with expansive experience, medical expertise and the confidence of agency staff and the American public needs to be nominated in short order,” they write.
CBS News spotlights how two MIT researchers have been named to key roles on the Biden administration’s science team. Prof. Eric Lander, president and founding director of the Broad Institute, has been nominated to lead the Office of Science and Technology Policy, and Maria Zuber, MIT’s vice president for research, will co-chair the President's Council of Advisors on Science and Technology. Zuber said she hopes to "restore trust in science, and pursue breakthroughs that benefit all people."
Prof. Eric Lander, president and founding director of the Broad Institute, and Maria Zuber, MIT’s vice president for research, have been nominated to leading roles on the Biden administration's science team, report Nidhi Subbaraman and Alexandra Witze for Nature. “These are excellent appointments, highly qualified and experienced, and well grounded in science,” says Rita Colwell, a professor at University of Maryland at College Park and former director of the National Science Foundation
AP reporter Seth Borenstein writes about how President-elect Joe Biden is nominating Prof. Eric Lander of the Broad Institute to serve as his chief science officer and lead the Office of Science and Technology Policy, and has selected Maria Zuber, vice president for research at MIT, to co-chair the President’s Council of Advisors on Science and Technology. Francis Collins, director of the NIH, called Lander, “brilliant, visionary, exceptionally creative and highly effective in aspiring others. I predict he will have a profound transformational effect on American science.”
New York Times reporter Carl Zimmer writes that Prof. Eric Lander, president and founding director of the Broad Institute, has been nominated to serve as director of the Office of Science and Technology Policy and to serve as a presidential science advisor. MIT Vice President for Research Maria Zuber will co-chair the President’s Council of Advisors on Science and Technology.
Prof. Eric Lander, president and founding director of the Broad Institute, has been nominated by President-elect Joe Biden to lead the Office of Science and Technology Policy, which Biden will make a Cabinet-level position, reports Sarah Kaplan for The Washington Post. Maria Zuber, MIT’s vice president for research, will co-chair the President’s Council of Advisors on Science and Technology.
TechCrunch reporter Jonathan Shieber spotlights Senti Biosciences, an MIT startup, which is developing cancer therapies using a new programmable biology platform. “The company’s technology uses new computational biological techniques to manufacture cell and gene therapies that can more precisely target specific cells in the body,” Shieber explains.
MIT researchers have discovered the molecular structure of a protein that plays a key role in the coronavirus’ ability to replicate itself and stimulate the host cell’s inflammation response, reports Travis Anderson for The Boston Globe. “If researchers can find a way to ‘block this channel,’” writes Anderson, “then they might be able to reduce the ‘pathogenicity of the virus’ and also obstruct viral replication.”
Professor Angelika Amon, an award-winning cell biologist and “an advocate for the kinds of studies that grind away outside of the limelight,” died on Oct. 29, reports Bryan Marquard for The Boston Globe. Amon’s daughter, Clara Weis, noted that Amon “was pretty much the best role model there is. She was very caring and understanding. She always knew what was happening and how to deal with it the right way.”
Times Higher Ed reporter Matthew Reisz memorializes the life and work of Prof. Angelika Amon, a “trailblazing” scientist known for her research into the life cycle of cells. “Angelika existed in a league of her own,” says Whitehead fellow Kristin Knouse. “She had the energy and excitement of someone who picked up a pipette for the first time, but the brilliance and wisdom of someone who had been doing it for decades.”
Writing for The Boston Globe, Prof. Eric Lander, president and founding director of the Broad Institute, argues that the U.S. needs to take steps to ensure that "science benefits society and society trusts science…In the 2020s, the decision-making must include a much wider range of people, who will need to be prepared to grapple thoughtfully with hard choices.”
Writing for The Washington Post, Prof. Harvey Lodish emphasizes the importance of foreign workers and immigrants to the U.S. economy. “Without students and workers from outside the U.S., it’s difficult to see how the current successes of U.S. scientific research and innovation could continue,” writes Lodish.
A new study by MIT researchers explores how cellular guides in planarians appear to provide a roadmap for regeneration, reports Veronique Greenwood for The New York Times. Greenwood notes that the findings “may someday help scientists interested in helping humans regenerate injured neurons.”